Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

The Tumor Microenvironment

The Tumor Microenvironment

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Distinct immune landscapes characterize highly versus minimally invasive brain metastases.

JCI insight·2026

Same author

Checkpoint blockade and the stem-like T cell trade-off.

Molecular oncology·2026

Same author

Insights into a long life without cancer: The case of the bowhead whale.

Molecular oncology·2026

Same author

Tumor-derived aminopeptidase N promotes early stages of brain metastatic colonization.

Cell reports·2026

Same author

European cancer research requires renewed urgency.

Nature cancer·2025

Same author

The evolving landscape of brain metastasis: volume II.

Trends in cancer·2025

Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026

Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026

Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026

Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026

Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026

Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 19, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Cancer ecosystems: A dynamic interplay across scales.

Daniela F Quail¹, Johanna A Joyce²

¹Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada; Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, QC, Canada; Department of Physiology, McGill University, Montreal, QC, Canada.

|April 17, 2026

Summary

This summary is machine-generated.

Cancer progresses within complex ecosystems. This study proposes a multi-scale framework to reprogram tumor-sustaining networks, integrating organismal physiology for durable cancer therapy.

More Related Videos

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Published on: April 4, 2025

Related Experiment Videos

Last Updated: Apr 19, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Published on: April 4, 2025

Area of Science:

Oncology
Systems Biology
Cancer Research

Background:

Tumors exist in complex, adaptive ecosystems influenced by local and systemic factors.
Cancer progression depends on interactions within the tumor microenvironment and the host macroenvironment.
Current therapies often focus on eliminating malignant cells, neglecting the broader biological context.

Purpose of the Study:

To propose a multi-scale framework uniting tumor biology and organismal physiology.
To reframe cancer therapy from cell elimination to network reprogramming.
To highlight emerging approaches for restoring physiological equilibrium in cancer treatment.

Main Methods:

Multi-scale framework integrating tumor biology and organismal physiology.
Review of emerging therapeutic approaches.
Focus on spatial multi-omics and AI-driven pathology.
Exploration of immune-vascular normalization and physiological conditioning.

Main Results:

A framework that views cancer therapy as reprogramming of disease-sustaining networks.
Identification of novel strategies to restore physiological balance.
Integration of local tumor biology with systemic host factors for therapeutic design.

Conclusions:

An integrative vision for precision oncology is presented.
Bridging discovery and intervention is key to achieving durable cancer therapy.
Reprogramming cellular, vascular, and systemic networks offers a path toward curative cancer treatment.